Nyxoah Shareholding Changes
Analysis based on 9 articles · First reported Jun 17, 2026 · Last updated Jun 29, 2026
The market impact on Nyxoah is neutral to slightly positive due to significant acquisitions by Orin Hirschman and Robert Taub, indicating increased investor confidence. However, passive decreases by Cochlear, ResMed, and Healthcare Holding Schweiz could offset some of this positive sentiment, suggesting a rebalancing of institutional holdings.
Nyxoah SA has announced several transparency notifications regarding changes in large shareholdings. Orin Hirschman, through controlled entities, increased his stake to 14.55%, crossing the 10% threshold. Robert Taub, with Robelga SRL, also increased his holding to 14.50%, surpassing the 10% threshold. Pierre-Édouard Stérin, via B.A.D. 21 SRL, acquired voting securities, reaching 7.23% and crossing the 5% threshold. Conversely, Cochlear's holding passively decreased from 14.999% to 5.85%, falling below the 10% threshold. ResMed and Healthcare Holding Schweiz also reported passive downward crossings of the 3% threshold. Bank of America reported both an acquisition and a disposal of voting securities and financial instruments, crossing the 3% threshold in both instances.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard